Early research (Phase 1)UnknownNCT06027853What this trial is testingNatural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid LeukemiaWho this might be right forAML, Adult Zhejiang University 24
Testing effectiveness (Phase 2)Ended earlyNCT00185679What this trial is testingHaploid Allogeneic Transplant Using the CliniMACS SystemWho this might be right forAcute Myelogenous Leukemia (AML) - Relapsed, Primary Refractory Disease or Poor Risk FactorsChronic Myelogenous Leukemia (CML) - Accelerated or Second Chronic PhaseMyelodysplastic Syndrome (MDS) - High and Intermediate Risk+2 more Ginna Laport 13
Testing effectiveness (Phase 2)UnknownNCT04946890What this trial is testingMRX2843 in Subjects With Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Leukemia Betta Pharmaceuticals Co., Ltd. 104
Testing effectiveness (Phase 2)Study completedNCT04079296What this trial is testingA Study Investigating the Safety, Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)Who this might be right forAcute Myeloid Leukemia (AML)Myelodysplastic Syndrome Astellas Pharma Global Development, Inc. 43
Early research (Phase 1)Ended earlyNCT01643603What this trial is testingDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMyeloid Leukemia+3 more Barbara Ann Karmanos Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Study completedNCT01164709What this trial is testingNelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more Swiss Cancer Institute 18
Early research (Phase 1)Ended earlyNCT02635074What this trial is testingIbrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forRecurrent Adult Acute Myeloid Leukemia Steven E. Coutre 2
Not applicableNot Yet RecruitingNCT06385808What this trial is testingEfficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AMLWho this might be right forRelapse LeukemiaRefractory Acute Myeloid LeukemiaConditioning+1 more First Affiliated Hospital Xi'an Jiaotong University 37
Not applicableStudy completedNCT03860376What this trial is testingEx Vivo Drug Sensitivity Testing and Mutation ProfilingWho this might be right forRecurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more Florida International University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07562568What this trial is testingSHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDSWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMDS+4 more The First Affiliated Hospital of Soochow University 160
Early research (Phase 1)Study completedNCT00079378What this trial is testingDecitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)UnknownNCT01180426What this trial is testingExtension Study With Tosedostat in Relapsed/Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Chroma Therapeutics 30
Early research (Phase 1)Study completedNCT05829226What this trial is testingStudy With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)Who this might be right forAML, Adult RecurrentMDS PureTech 101
Early research (Phase 1)Looking for participantsNCT05945849What this trial is testingCD33KO-HSPC Infusion Followed by CART-33 Infusion(s) for Refractory/Relapsed AMLWho this might be right forLeukemia, Myeloid, Acute University of Pennsylvania 16
Testing effectiveness (Phase 2)UnknownNCT05055791What this trial is testingEvaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic MalignanciesWho this might be right forAcute Myeloid LeukemiaLymphomaMultiple Myeloma CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 312
Very early researchNot Yet RecruitingNCT04599543What this trial is testingIL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Zhejiang University 36
Early research (Phase 1)Ended earlyNCT06714591What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1Who this might be right forRelapsed/Refractory Acute Myeloid Leukemia SystImmune Inc. 52
Testing effectiveness (Phase 2)Study completedNCT03050216What this trial is testingQUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AMLWho this might be right forAcute Myeloid Leukemia Masonic Cancer Center, University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT04112589What this trial is testingA Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First TreatmentWho this might be right forAcute Myeloid Leukemia PETHEMA Foundation 63